Pfizer Inc



    Today's change

    0.02 / +0.05%

    1 year change


    As of Jul 27 2016 21:00 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. Fast FT

    3 hours ago

    AstraZeneca insists new drugs 'advancing quickly' as revenues drop

    Loss of market exclusivity on key products, as well as restructuring costs, have weighed on first half results from UK...

  2. July 24, 2016

    Bloodlines: Rivals look to create ‘off-the-shelf’ treatment

    Most of the companies pursuing Car-T therapies are developing products that modify cells taken from the patient’s own...

Special Reports

  1. Combating Cancer

    We consider the latest in cell therapy and efforts to arm the immune system in the fig...
  2. FT Health: Vaccines

    In today’s connected world, where outbreaks of infectious disease can spread faster th...
Search more Special Reports on this topic.

  1. July 20, 2016

    The unhappy story of British industrial strategy

    Industrial strategy is back in fashion. Theresa May, the UK prime minister, has signalled her approval with a...

  2. Fast FT

    July 19, 2016

    Health insurers sink as DoJ said to prepare suits

    Shares in healthcare insurers were sinking fast on Tuesday after reports emerged that US anti-trust officials were...

  3. July 15, 2016

    Ireland can conjure a pot of sovereign wealth gold

    We are told that the Irish economy grew by 26 per cent in 2015. Fortune is indeed looking up in Ireland: unemployment...

  4. July 14, 2016

    Biosimilars set to compete with two of world’s biggest drug franchises

    The world’s top grossing drug, Humira, generated $14bn in global sales last year for AbbVie, the Chicago-based...

  5. Fast FT

    July 7, 2016

    Humana dives on antitrust concern report

    Is another multibillion dollar merger deal about to bite the dust? Shares in health insurer Humana tumbled more 11 per...

  6. July 6, 2016

    Medivation: scarcity value

    One must be a careful about criticising big pharma companies for splashing the cash on smaller, essentially one-product...

  7. July 6, 2016

    Medivation confident drugs pipeline will win over suitors

    After two years of furious dealmaking in the pharmaceuticals industry, large drugmakers have started to complain there...

  8. July 5, 2016

    Medivation agrees to $10bn takeover talks

    Medivation, the US biotech company, has agreed to hold talks about a $10bn sale with large global pharmaceutical groups...

  9. Fast FT

    July 5, 2016

    Medivation agrees to $10bn sale talks with Sanofi

    US biotech company Medivation has agreed to hold talks with Sanofi, France’s largest pharma group, about a potential...

  10. June 17, 2016

    Wall Street endures second straight weekly loss

    US stocks suffered a second straight weekly decline on Friday, weighed down by the technology and healthcare sectors....

  11. Fast FT

    June 3, 2016

    GSK's HIV unit secures biggest ever tender in sub-Saharan Africa

    GlaxoSmithKline’s HIV drugs business, ViiV Healthcare, has secured its biggest ever tender in sub-Saharan Africa that...

  12. June 2, 2016

    President raises patient and business hope for cancer treatment

    When Jimmy Carter was diagnosed last year with melanoma that had spread to his brain, many people feared the worst for...

  13. June 2, 2016

    M&A back on the table as ‘big pharma’ targets smaller rivals

    After a start to the year marred by an accounting scandal at Valeant, the collapse of Pfizer’s $160bn merger with...

  14. June 1, 2016

    Cancer doctors face next drug challenge

    More than 30,000 doctors and scientists will gather in Chicago this weekend for the biggest annual meeting of cancer...

  15. Fast FT

    May 31, 2016

    Allergan gains as Icahn discloses 'large position'

    Shares in Botox maker Allergan are getting a facelift of sorts on Tuesday. The stock rose by as much as 3.1 per cent in...

  16. May 24, 2016

    Tax inversion crackdown claims $8bn fertiliser deal

    A US government crackdown on tax inversions has prompted two fertiliser makers to scrap their $8bn deal because it...

  17. FT Alphaville

    May 20, 2016

    Friday RAW: are bidders circling Sobi again?

    Lately, M&A reporting has been going a bit gonzo. This week alone we’ve had a recruitment website claim that Occidental...

  18. May 16, 2016

    Freeport-McMoRan gains ground on broker upgrade

    Freeport-McMoRan was one of the leading gainers on the S&P 500 on Monday after analysts at Cowen & Co boosted their...

  19. May 16, 2016

    Pfizer buys Anacor for $5.2bn to boost innovation

    Pfizer has agreed to buy the Silicon Valley biotech group Anacor for $5.2bn, as it continues to build up the innovative...

  20. May 16, 2016

    Biotech groups sink their teeth into the Big Apple

    When Cellectis, a French biotech group, opened a US subsidiary last year, it dispensed with tradition and picked an...

  21. Fast FT

    May 16, 2016

    Pfizer snaps up Anacor for $5.2bn

    It’s no Allergan. But barely a month after it scrapped plans to acquire its rival, Pfizer has found a new acquisition...

  22. May 14, 2016

    Pfizer blocks its drugs from use in executions

    Pfizer has taken steps to ensure that none of its products are used in lethal injections, the largest US drugmaker said...

  23. May 11, 2016

    Staples tie-up with Office Depot halted by US regulators

    Staples and Office Depot became the latest victims of US regulators, as the two largest stationery retailers in America...

  24. Fast FT

    May 10, 2016

    US judge blocks Staples, Office Depot tie-up

    A federal judge ruled on Tuesday in favour of the US government’s request for an injunction to halt the merger between...

  25. May 10, 2016

    Norwegian Cruise Line shares fall on downbeat outlook

    Norwegian Cruise Line shares fell on Tuesday after the company issued a downbeat second-quarter earnings outlook,...

  26. May 10, 2016

    Allergan: kicking the habit

    Cold turkey is not always the best way to kick addiction. Sometimes an intermediate step is needed. For Allergan, the...

  27. Fast FT

    May 10, 2016

    Allergan plans $10bn share buyback

    Allergan, the maker of Botox, said it would buy back up to $10bn of its stock, sending shares in the company up by 5...

  28. May 9, 2016

    Pfizer to trial triple-combination cancer treatment

    Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make...

  29. May 8, 2016

    Allergan chief persists with his prescription for growth

    When Brent Saunders, chief executive of Allergan, agreed to sell the drugmaker to Pfizer for $160bn in November last...

  30. May 6, 2016

    Cellectis hails success in ridding British infant of cancer

    A second child with a previously incurable form of leukaemia has been successfully treated with an important new cell...

  31. May 3, 2016

    Pfizer weighs split to cut tax bill

    Pfizer is looking for new ways to cut its US tax bill including moving part of its business overseas following a...

  32. Fast FT

    May 3, 2016

    Pfizer hunts for new ways to cut tax bill

    Ian Read, chief executive of Pfizer, has suggested moving part of the drugmaker to a low-tax jurisdiction following a...

  33. Fast FT

    May 3, 2016

    Pfizer tops forecasts, lifts guidance

    Shares in Pfizer have jumped almost 3 per cent in pre-market trading after the US drugmaker reported first quarter...

  34. Fast FT

    May 3, 2016

    Markets: FX machinations lead to cautious mood

    Forex is in focus as the yen hits a fresh 18-month high, the dollar index slips to a 15-month low and the Aussie is...

  35. April 28, 2016

    What pawnbrokers can teach central banks

    Three decades ago, the club of triple A-rated American corporate borrowers was a busy place. About 60 big companies,...

  36. April 27, 2016

    Daniel Loeb warns of hedge fund ‘killing field’

    One of the most powerful US hedge fund managers believes that the industry is in “first innings of a washout” after a...

  37. April 25, 2016

    Drug prices: Tweaking the formula

    What is the value of a human life? It is one of the most fraught questions in public policy as governments around the...

  38. April 25, 2016

    Vaccine development needs global alliance

    Who has saved the most lives in human history? Claims can be made for various scientific pioneers and political...

Search for Pfizer Inc and